Medicare Enrolled

Dr. Jeffrey Arle, M.D., PH.D

Neurological Surgery · Burlington, MA
Mixed engagement
LAHEY CLINIC INC, Burlington, MA 01805
7817448000
In practice since 2006 (19 years)
NPI: 1528169851 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arle

Dr. Jeffrey Arle is a neurological surgery specialist in Burlington, MA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Arle received a total of $304,442 from 16 pharmaceutical and/or device companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurological surgery. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arle is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $304,442 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$304,442
Total received (2018-2024)
Avg $43,492/year across 7 years
Top 3% in MA for neurological surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
302
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100,817 (33.1%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$100,407 (33.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$97,910 (32.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,308 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,222
2023
$830
2022
$46,245
2021
$38,027
2020
$12,347
2019
$165,621
2018
$40,150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$481
Abbott Laboratories
$444
Medtronic, Inc.
$148
Nalu Medical, Inc.
$89
Orthofix Medical, Inc.
$43
Bioventus LLC
$17
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$110,388
Boston Scientific Corporation
$63,556
Abbott Laboratories
$49,205
Saluda Medical Americas, Inc.
$29,353
LivaNova USA, Inc.
$20,707
BOSTON SCIENTIFIC CORPORATION
$19,818
Wenzel Spine, Inc.
$9,957
Nevro Corp.
$405
Stimwave Technologies Incorporated
$297
Medtronic, Inc.
$266
UCB, Inc.
$135
NEUROPACE, INC.
$131
Nalu Medical, Inc.
$89
Cala Health, Inc.
$73
Orthofix Medical, Inc.
$43
Bioventus LLC
$17
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · BONESCALPEL & SONICONE (O.R.) · CALA TRIO · COVEREDGE · Cervical-Stim · CoverEdge 32 · DRG IPGs · DRG leads · EON C · Evoke SCS · FIXATE · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · General - Pain Management · INTELLIS · Nalu Neurostimulation System · PROCLAIM · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · RESTORE · RNS System · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · STEALTHSTATION S8 PLATFORM · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w/Receiver · VERCISE · VNS - Sentiva · VNS - Symmetry · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · Vanta · VariLift · Varilift · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (33%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for neurological surgery in MA.

Looking for a neurological surgery specialist in Burlington?
Compare neurological surgerists in the Burlington area by procedure volume, costs, and industry payment transparency.
Browse neurological surgerists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arle is a neurological surgery specialist, with mixed engagement industry engagement in the top 3% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Arle receive payments from pharmaceutical companies?
Yes. Dr. Arle received a total of $304,442 from 16 companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Arle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →